Cleared Traditional

Cryotop®US-flash and Cryotop®US-scoop (K181469) - FDA 510(k) Clearance

Class II Obstetrics & Gynecology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K181469 · Kitazato Corporation · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2018
Decision
158d
Days
Class 2
Risk

K181469 is an FDA 510(k) clearance for the Cryotop®US-flash and Cryotop®US-scoop. Classified as Labware, Assisted Reproduction (product code MQK), Class II - Special Controls.

Submitted by Kitazato Corporation (Fuji-Shi, JP). The FDA issued a Cleared decision on November 9, 2018 after a review of 158 days - an extended review cycle.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.6160 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Obstetrics & Gynecology review framework, consistent with the majority of Class II 510(k) submissions.

View all Kitazato Corporation devices

Submission Details

510(k) Number K181469 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 04, 2018
Decision Date November 09, 2018
Days to Decision 158 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
2d faster than avg
Panel avg: 160d · This submission: 158d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MQK Labware, Assisted Reproduction
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.6160
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Consultant

Emergo Global Consulting, LLC
Diane Sudduth

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MQK Labware, Assisted Reproduction

All 16
Devices cleared under the same product code (MQK) and FDA review panel - the closest regulatory comparables to K181469.
Pasteur Pipette 3mL, Pasteur Pipette 1mL
K201213 · Hertart Aps · Dec 2020
VitriGuard
K200815 · Origio A/S · Jun 2020
Rapid-i™ Kit
K181461 · Vitrolife Sweden AB · Jan 2019
VitriGuard
K180740 · Origio A/S · May 2018
ZyMot ICSI Sperm Separation Device, ZyMot Multi Sperm Separation Device (850µl, 3ml)
K173075 · Dxnow, Inc. · Mar 2018
iVitri Straw
K172751 · Reprobitech Corp. · Feb 2018